Hepatitis B Functional Cure Explained: What FDA Approval Means

A hepatitis B functional cure means the virus stays below detectable levels in your blood and you no longer need to keep taking medicine, even though the infection has not been wiped out completely. According to a ScienceAlert report, the US FDA has approved the first drug that offers this outcome for chronic hepatitis B. It is a real step forward, but it is not the same as the infection being erased from the body.

Below we explain the term in plain words, how it differs from a full cure, who might eventually benefit, and the questions worth taking to a doctor.

Key takeaways

• A functional cure means the surface antigen (HBsAg) disappears from the blood and the virus stays undetectable after treatment stops. Hidden viral DNA can remain in liver cells.
• Today's standard tablets usually control the virus for as long as you take them but rarely end the infection. A functional cure aims to let treatment stop.
• Approval in the US does not mean the drug is available, priced or approved in India. Our source notes give no such details.
• Vaccination, testing and regular liver check-ups matter just as much as before.

What did the FDA approve, and what do we actually know?

Our source for this article is a ScienceAlert headline reporting that the FDA approved the first drug offering a functional cure for chronic hepatitis B. The headline calls it a breakthrough and says it is the first of its kind.

That is all we can state with confidence. We have not been given the drug's name, who exactly it is approved for, how it is given, how often, how many patients reached a functional cure in trials, or what it costs. We will not guess at those. Before you act on any of this, read the official announcement on the FDA website or ask your liver specialist for the prescribing details.

What is a functional cure for hepatitis B?

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). In most healthy adults the immune system clears it within months. In some people, especially those infected as babies or young children, it becomes chronic and can stay for decades.

Chronic infection can quietly damage the liver over time, leading to scarring (cirrhosis) or liver cancer. Doctors track it with a few markers. The one that matters most here is HBsAg, the hepatitis B surface antigen. If it is positive for more than six months, the infection is generally considered chronic.

A functional cure is usually defined as:

• HBsAg is no longer detectable in the blood.
• HBV DNA (the viral load) is undetectable.
• This holds for a sustained period, typically at least six months, after treatment has stopped.

In everyday terms, the virus is switched off and your immune system keeps it under control without daily medicine. Think of a fire that has been put out, while a few embers may still sit in the ashes.

Functional cure vs full cure: what is the difference?

The embers are the key difference. When HBV infects a liver cell, it can leave a stable copy of its genetic material, called cccDNA, inside the nucleus. It can also insert pieces of viral DNA into the cell's own DNA. Current drugs do not remove either of these.

A full, or sterilising, cure would remove all of it. That has not been achieved with any approved treatment. A functional cure accepts that some traces may remain but aims for a state where they do no harm.

So, is hepatitis B curable?

The honest answer is: partly, and it depends on what you mean by cure. Acute hepatitis B in an adult usually clears on its own. Chronic hepatitis B has so far been treated, not cured, in most people. The new approval is the first time a drug is described as delivering a functional cure, which is a meaningful change from lifelong suppression.

How is chronic hepatitis B treated at the moment?

Most people who need treatment take antiviral tablets such as tenofovir or entecavir. They are generally well tolerated and keep the viral load very low, which protects the liver. The catch is that stopping them often lets the virus rebound, so many people take them for years or for life.

Not everyone with chronic hepatitis B needs treatment right away. Doctors decide based on liver enzymes (ALT), viral load, the state of the liver on scans or elastography, age and family history of liver cancer. Some people are simply monitored every six to twelve months.

A simple example of what functional cure looks like on a report

This is an illustration, not a real patient. Say a 38-year-old man has been on a daily antiviral for eight years. His reports show HBsAg positive, HBV DNA undetectable because of the tablet, and normal liver enzymes.

If he were treated with a functional-cure approach and it worked, his later reports would show HBsAg negative, HBV DNA still undetectable, and enzymes normal, all after he had stopped treatment. His doctor would still keep checking him at intervals. The result is a durable remission rather than a guarantee.

Who could this help?

We do not know the approved patient group from our source notes, so treat the following as general expectations, not eligibility rules. Functional-cure treatments in general are aimed at adults with chronic hepatitis B who already have the virus under control or are being actively managed. People with advanced cirrhosis, those who are pregnant, children, and people with other infections such as HIV or hepatitis D often need a separate, specialist decision.

If you have hepatitis B, the label on the approval will matter more than the headline. Your hepatologist can read it against your own reports.

Myth vs fact

• Myth: A functional cure means I can stop all check-ups.
  Fact: People who clear HBsAg, especially those with earlier cirrhosis or a family history of liver cancer, may still need periodic liver monitoring. Your doctor will set the schedule.
• Myth: Once HBsAg is negative, the virus can never return.
  Fact: Traces can stay in the liver. If the immune system is strongly suppressed, for example by chemotherapy or some arthritis and cancer drugs, the virus can reactivate. Tell every treating doctor about your hepatitis B history.
• Myth: The vaccine is no longer needed.
  Fact: Prevention is still the best protection. The vaccine prevents infection in the first place and remains the main tool for families and newborns.

Questions to ask your doctor

Take this list to your next appointment. It works whether you are newly diagnosed or have lived with hepatitis B for years.

1. Is this new drug approved for someone with my type and stage of hepatitis B?
2. What percentage of people like me reached a functional cure in the trials, and how long did it last?
3. What are the side effects, and how would you monitor me?
4. Do I need to stay on my current tablet during or after this treatment?
5. If the virus returns, what is the plan?
6. Will I still need ultrasound or liver cancer screening after a functional cure?
7. Is the drug approved or available in India, and when might that happen?
8. What would it cost, and would health insurance cover it?

On that last point, new drugs often arrive in India in stages, with brand prices first and cheaper versions later. Our piece on how GLP-1 drug prices, generics and insurance work in India shows how that pattern can play out for another new medicine, though hepatitis B treatment will have its own timeline.

Hepatitis B symptoms and testing in India

Many people with hepatitis B feel perfectly fine for years. When symptoms appear, they can include tiredness, nausea, loss of appetite, dark urine, pale stools, pain in the upper right abdomen, and yellowing of the eyes or skin. Absence of symptoms does not mean absence of infection.

Hepatitis B spreads through blood, unprotected sex, shared needles and from mother to baby at birth. It does not spread through casual contact, hugging, sharing food or coughing.

A basic evaluation usually includes:

• HBsAg, to check for current infection.
• Anti-HBs, to see whether you are immune through vaccination or past infection.
• Total anti-HBc, a marker of past or present exposure.
• HBV DNA, ALT and an ultrasound or FibroScan if the first test is positive.

In India, testing is available at most diagnostic labs and government hospitals, and the national programme for viral hepatitis offers testing and treatment at public facilities. The details and reach of that programme vary by state, so check with your district hospital or a gastroenterologist. Pregnant women are routinely advised to be screened, and newborns of infected mothers need the vaccine and sometimes immunoglobulin soon after birth, as advised by the doctor.

Common mistakes to avoid

• Stopping your antiviral tablet on your own because you read about a functional cure. A sudden stop can cause a flare-up.
• Treating a positive HBsAg report as a final verdict without seeing a liver specialist.
• Skipping family screening. Partners and household members should be tested and vaccinated if they are not immune.
• Relying on herbal or social-media remedies that claim to cure hepatitis B.

FAQ

What is the difference between a functional cure and a cure for hepatitis B?

A functional cure means HBsAg and the viral load are undetectable without ongoing treatment, though viral DNA may remain hidden in liver cells. A full cure would remove all traces of the virus. No approved drug has done the latter.

Has the FDA really approved a hepatitis B cure?

According to a ScienceAlert report, the FDA has approved the first drug offering a functional cure for chronic hepatitis B. That is not the same as a complete cure, and our notes do not include the drug's name or full approval terms. Check the official FDA announcement.

Will this drug be available in India?

We cannot say. Approval in the US does not automatically mean approval, launch or pricing in India. That depends on Indian regulators and the manufacturer, so ask your specialist for updates.

Can I stop my hepatitis B tablets now?

No, not without your doctor's advice. Stopping antivirals abruptly can lead to a rebound of the virus and, in some people, a serious liver flare. Any change should be planned and monitored.

Do I still need the hepatitis B vaccine?

Yes, if you are not already immune. The vaccine prevents infection, including mother-to-child transmission when given on time, and a new treatment for people who already have the virus does not replace it.

Bottom line

The reported approval is encouraging because it moves hepatitis B treatment from lifelong control towards the possibility of stopping medicine. It is still a functional cure, not an eradication, and many details are unknown to us. If you or a family member has hepatitis B, book a review with a hepatologist or gastroenterologist, carry your latest HBsAg, HBV DNA and liver reports, and use the questions above. If you have never been tested, ask for a simple HBsAg test.